Lataa...
Role of lapatinib alone or in combination in the treatment of HER2-positive breast cancer
PURPOSE: This review aims to present the preclinical and clinical data regarding efficacy and safety of lapatinib alone and in combination with other agents in the treatment of human epidermal growth factor receptor-2 (HER2)-overexpressing breast cancer. BACKGROUND: HER2-positive (HER2+) breast canc...
Tallennettuna:
| Päätekijät: | , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Dove Medical Press
2012
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3846547/ https://ncbi.nlm.nih.gov/pubmed/24367193 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/BCTT.S29996 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|